Abstract
(Can J Anaesth. 2017;64(8):820–827) Despite the use of prophylactic agents like oxytocin, the rise in postpartum hemorrhage (PPH) between 2003 and 2010 has been attributed to postpartum uterine atony. Oxytocin reduces PPH by up to 60% when used during the third stage of labor. However, oxytocin is associated with an increased risk of PPH secondary to uterine atony when used for labor augmentation that results in prolonged infusions or high doses. Myometrial oxytocin receptors (OTRs) may be less responsive to oxytocin administered to prevent PPH because the OTRs have become desensitized when exposed to oxytocin during labor augmentation. It is unclear if OTRs can become resensitized after a cessation of oxytocin. This study aimed to assess the association between blood loss and the interval of time between discontinuing oxytocin and cesarean delivery (CD).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callSimilar Papers
More From: Obstetric Anesthesia Digest
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
